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Synthesis of-4-((4-trimethylsilyl-1H-1,2,3-triazol-1-yl)methyl)- 
2H-chromen-2-ones: A novel class of heteroaryl anionic 
synthon 
Sowmiya Carmel Y, Noor Shahina Begum, Prasad N L, and Hari Prasad Suresh 
Department of Post-Graduate Studies in Chemistry, Bangalore University, Bangalore, India  
ABSTRACT 
A one-pot synthesis of some novel anionic scaffolds: the substituted-4- 
((4-trimethylsilyl-1H-1,2,3-triazol-1-yl)methyl)-2H-chromen-2-one is 
reported. Reaction of 10 different substituted bromomethylcoumarins 
with trimethylsilylacetylene and sodium azide in the presence of 
copper(I) iodide catalyst gave the corresponding heteroaryl conju-
gates: the substituted-4-((4-trimethylsilyl-1H-1,2,3-triazol-1-yl)methyl)- 
2H-chromen-2-one in 70–92% yields. The structures of the synthesized 
compounds have been completely characterized by spectral and 
elemental analyses. For the first time, the representative single-crystal 
X-ray structure analysis of 6-methoxy-4-((4-trimethylsilyl-1H-1,2, 
3-triazol-1-yl)methyl)-2H-chromen-2-one is reported which 
confirms the formation of anionic synthon which bears the 
trimethylsilyl-group.  
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Introduction 
The concept of hybrid pharmacophore approach has led to a detailed study of possible 
biosynergizing of some pharmacologically important heterocyclic compound conjugates. 
It is well established that a combination of diverse heterocyclic cores in one molecule 
often leads to new pharmacological profiles with increased biological activity and reduced 
toxicity of the newly synthesized hybrid molecules.[1] 
Literature survey reveals that coumarinyl backbone in assimilation with some 
nitrogen-containing heterocyclic moieties such as triazoles significantly increases the 
antimicrobial activity and broadens their antimicrobial spectrum. In recent years, a 
library of coumarin derivatives conjugated with 1,2,3-triazole has gained paramount 
importance in various fields of bioactivity and has also evoked much attention in 
forming scaffolds in numerous synthetic methodologies.[2–4] However, to our knowl-
edge, most of the reported conjugate molecules have not been converted into active 
pharmacodynamic agents. 
The 1,2,3-triazole moiety by itself is a versatile heterocycle with a diverse range of 
biological activities.[5] In this regard, the substitution of trimethylsilyl group at position 
4 of the triazoyl moiety would lead to the formation of novel anionic synthons. The 
synthons are further regiospecifically transformed to form larger molecules with a wide 
range of chemical and pharmacological properties. The transformations would exploit 
the α- and β-silyl effects. 
One of the important routes for the preparation of triazole moieties is using Sharpless 
click chemistry.[6] The methodology uses 1,3-dipolar cycloaddition of alkynes and azides to 
form N1-substituted 1,2,3-triazoles in the presence of a Cu(I) catalyst.[7] 
Our laboratory deals with the synthesis and reactions of organosilyl-based reagents.[8] In 
this piece of work, we report for the first instance of time, the synthesis of some novel 
conjugate heterocyclic scaffolds: the substituted-4-((4-trimethylsilyl-1H-1,2,3-triazol-1-yl) 
methyl)-2H-chromen-2-ones. The molecules, we expect, would serve as precursors for 
Scheme 1. Reagents and conditions: 1a–j (2 mmol); trimethylsilylacetylene (2 mmol); sodium azide 
(1.5 mmol); and CuI (1 µmol)—10 mL acetone/water (1:1), 0–28 °C, stirring 8 h.  
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the synthesis of larger molecules with a wide range of chemical and pharmocodynamic 
properties.[9] 
The one-pot reaction of 4-bromomethylcoumarins 1a–j with trimethylsilylacetylene 
(TMSA) and sodium azide in the presence of CuI catalyst in acetone/water solvent system 
over 8 h yielded the novel anionic synthons: the substituted-4-((4-trimethylsilyl-1H-1,2, 
3-triazol-1-yl)methyl)-2H-chromen-2-one. 2a–j in 70–92% yields (Scheme 1). 
Results and discussion 
The 4-bromomethylcoumarins 1a–j were synthesized using Pechmann cyclization of 
substituted phenols with 4-bromoethylacetoacetate in the presence of concentrated 
H2SO4 as a dehydrating agent.[10] 
Individually, stirring a mixture of 4-bromomethylcoumarins (1a–j), sodium azide, 
TMSA, and copper(I) iodide catalyst in 1:1 acetone/water at 0 °C to ambient temperature 
over 8 h yielded the trimethylsilyl-substituted triazolylcoumarins 2a–j conjugates in 
70–92% isolated yields as depicted in Scheme 1. The optimum yields of the products are 
given in Table 1. 
In this regard, we now wish to report for the first instance of time, the single-crystal 
XRD of the conjugate anionic synthon: the trimethylsilyl-bearing coumarinyltriazolyl com-
pound 2a. We were able to isolate 2a as good single crystals by slow evaporation technique 
for X-ray structure analysis. The ORTEP view of 2a is given in Figure 1. 
To our knowledge, there exist no reports for the single-crystal XRD of such conjugate 
anionic synthons bearing the trimethylsilyl group. Therefore, we now report for the first 
instance of time the trimethylsilyl-bearing multifunctional heterocycle conjugate molecule. 
The complete details of XRD characterization is provided in supplementary material.[11–17] 
The possible mechanism for formation of products 2a–j is reasoned to go through the 
cycle as highlighted in Scheme 2. The mechanism follows the path as given by Worell 
et al.[18] 
Figure 1. ORTEP view of 6-methoxy-4-((4-trimethylsilyl-1H-1,2,3-triazol-1-yl)methyl)-2H-chromen-2- 
one (2a).  
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Table 1. Synthesis of-4-((4-trimethylsilyl-1H-1,2,3-triazol-1-yl)methyl)-2H-chromen-2-ones 2a–j. 
Entry Reactant Product Yield (%)  
a 87 
b 81 
c 72 
d 82 
e 94 
f 90 
g 97 
h 91 
i 95 
j 70   
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Experimental section 
General procedure for the preparation of substituted-4-((4-trimethylsilyl-1H- 
1,2,3-triazol-1-yl)methyl)-2H-chromen-2-one (2a–j) 
To an ice-cold suspension of differently substituted bromomethyl coumarins 1a–j 
(2 mmol), sodium azide (1.5 mmol), and copper iodide (1 µmol) in 10 mL (1:1) of 
aqueous acetone was added dropwise trimethylsilyl acetylene (2 mmol) over a period 
of 30 min. The resultant mixture was allowed to attain room temperature and further 
stirred for a period of 8 h. The reactions were monitored by TLC and GC through 
microworkup of aliquots. After the completion of reaction as indicated by the chroma-
tograms, excess acetone was removed under rotary evaporation and crude product was 
purified by column chromatography, using silica gel (100–200 mesh) and 2:5 ethyl 
acetate—petroleum benzine (60–74 °C fraction) to obtain compounds 2a–j. The 
isolated yields are reported in Table 1. The representative spectral details for 2a is given 
in the following, and the single-crystal XRD details are given in the supplementary 
material. 
6-Methoxy-4-((4-trimethylsilyl-1H-1,2,3-triazol-1-yl)methyl)-2H-chromen-2-one (2a): 
The product was obtained as yellow solid (87%); Melting point: 180–184 °C; IR (cm−1): 
3130, 2968, 2851, 1713, 1574, 1493, 1423, 1348, 1244, 1163, 1107, 1028, 941,841, 762, 
631, 575, 511; 1H NMR: (400 MHz, CDCl3, δ/ppm) 0.33 (s, 9 H), 3.82 (s, 3H), 5.72 (s, 2 
H), 6.07 (s, 1 H), 7.08 (d, J ¼ 2.8 Hz, 1 H), 7.15 (dd, J ¼ 6.4 Hz, 1 H), 7.31 (d, J ¼ 9.2 Hz, 
1 H), 7.57 (s, 1 H); 13C NMR: (100 MHz, CDCl3, δ/ppm): −1.0, 49.9, 56.1, 106.3, 115.9, 
117.5, 118.6, 120.3, 129.4, 148.0, 148.3, 156.4, 160.2; CHNS: Calculated C: 58.34%, H: 
5.81%, N: 12.76%; Found C: 58.28%, H: 5.80%, N: 12.72%. 
Scheme 2. Mechanism for the formation of products 2a–j.  
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